Integrated BioPharma, Inc.

INBP · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Assets
Cash & Equivalents$3,615$1,677$1,316$331
Short-Term Investments$0$0$0$0
Receivables$5,430$4,668$4,511$4,888
Inventory$9,362$11,244$10,261$11,055
Other Curr. Assets$356$286$284$352
Total Curr. Assets$18,763$17,875$16,372$16,626
Property Plant & Equip (Net)$2,749$3,675$4,276$3,777
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$3,337$4,601$4,726$4,798
Other NC Assets$52$56$57$49
Total NC Assets$6,138$8,332$9,059$8,624
Other Assets$0$0$0$0
Total Assets$24,901$26,207$25,431$25,250
Liabilities
Payables$2,267$2,510$2,266$3,209
Short-Term Debt$1,358$1,904$1,860$643
Tax Payable$0$0$0$0
Deferred Revenue$0$0-$2,266$0
Other Curr. Liab.$623$1,709$702$1,411
Total Curr. Liab.$4,248$6,123$4,828$5,263
LT Debt$336$846$1,742$1,412
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$336$846$1,742$1,412
Other Liabilities$0$0$0$0
Cap. Leases$1,015$1,798$2,672$1,869
Total Liabilities$4,584$6,969$6,570$6,675
Equity
Pref Stock$0$0$0$0
Common Stock$62$60$60$60
Retained Earnings-$31,419-$32,227-$32,339-$32,305
AOCI$0$0$0$0
Other Equity$51,674$51,405$51,140$50,820
Total Equity$20,317$19,238$18,861$18,575
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$24,901$26,207$25,431$25,250
Net Debt-$1,921$1,073$2,286$1,724